Lactococcus lactis Expressing Type I Interferon From Atlantic Salmon Enhances the Innate Antiviral Immune Response In Vivo and In Vitro

In salmon farming, viruses are responsible for outbreaks that produce significant economic losses for which there is a lack of control tools other than vaccines. Type I interferon has been successfully used for treating some chronic viral infections in humans. However, its application in salmonids d...

Full description

Bibliographic Details
Published in:Frontiers in Immunology
Main Authors: Muñoz, Carlos, González-Lorca, Josue, Parra, Mick, Soto, Sarita, Valdes, Natalia, Sandino, Ana María, Vargas, Rodrigo, González, Alex, Tello, Mario
Format: Text
Language:English
Published: Frontiers Media S.A. 2021
Subjects:
Online Access:http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406758/
https://doi.org/10.3389/fimmu.2021.696781
id ftpubmed:oai:pubmedcentral.nih.gov:8406758
record_format openpolar
spelling ftpubmed:oai:pubmedcentral.nih.gov:8406758 2023-05-15T15:29:58+02:00 Lactococcus lactis Expressing Type I Interferon From Atlantic Salmon Enhances the Innate Antiviral Immune Response In Vivo and In Vitro Muñoz, Carlos González-Lorca, Josue Parra, Mick Soto, Sarita Valdes, Natalia Sandino, Ana María Vargas, Rodrigo González, Alex Tello, Mario 2021-08-12 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406758/ https://doi.org/10.3389/fimmu.2021.696781 en eng Frontiers Media S.A. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406758/ http://dx.doi.org/10.3389/fimmu.2021.696781 Copyright © 2021 Muñoz, González-Lorca, Parra, Soto, Valdes, Sandino, Vargas, González and Tello https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. CC-BY Front Immunol Immunology Text 2021 ftpubmed https://doi.org/10.3389/fimmu.2021.696781 2021-09-05T01:09:49Z In salmon farming, viruses are responsible for outbreaks that produce significant economic losses for which there is a lack of control tools other than vaccines. Type I interferon has been successfully used for treating some chronic viral infections in humans. However, its application in salmonids depends on the proper design of a vehicle that allows its massive administration, ideally orally. In mammals, administration of recombinant probiotics capable of expressing cytokines has shown local and systemic therapeutic effects. In this work, we evaluate the use of Lactococcus lactis as a type I Interferon expression system in Atlantic salmon, and we analyze its ability to stimulate the antiviral immune response against IPNV, in vivo and in vitro. The interferon expressed in L. lactis, even though it was located mainly in the bacterial cytoplasm, was functional, stimulating Mx and PKR expression in CHSE-214 cells, and reducing the IPNV viral load in SHK-1 cells. In vivo, the oral administration of this L. lactis producer of Interferon I increases Mx and PKR expression, mainly in the spleen, and to a lesser extent, in the head kidney. The oral administration of this strain also reduces the IPNV viral load in Atlantic salmon specimens challenged with this pathogen. Our results show that oral administration of L. lactis producing Interferon I induces systemic effects in Atlantic salmon, allowing to stimulate the antiviral immune response. This probiotic could have effects against a wide variety of viruses that infect Atlantic salmon and also be effective in other salmonids due to the high identity among their type I interferons. Text Atlantic salmon PubMed Central (PMC) Frontiers in Immunology 12
institution Open Polar
collection PubMed Central (PMC)
op_collection_id ftpubmed
language English
topic Immunology
spellingShingle Immunology
Muñoz, Carlos
González-Lorca, Josue
Parra, Mick
Soto, Sarita
Valdes, Natalia
Sandino, Ana María
Vargas, Rodrigo
González, Alex
Tello, Mario
Lactococcus lactis Expressing Type I Interferon From Atlantic Salmon Enhances the Innate Antiviral Immune Response In Vivo and In Vitro
topic_facet Immunology
description In salmon farming, viruses are responsible for outbreaks that produce significant economic losses for which there is a lack of control tools other than vaccines. Type I interferon has been successfully used for treating some chronic viral infections in humans. However, its application in salmonids depends on the proper design of a vehicle that allows its massive administration, ideally orally. In mammals, administration of recombinant probiotics capable of expressing cytokines has shown local and systemic therapeutic effects. In this work, we evaluate the use of Lactococcus lactis as a type I Interferon expression system in Atlantic salmon, and we analyze its ability to stimulate the antiviral immune response against IPNV, in vivo and in vitro. The interferon expressed in L. lactis, even though it was located mainly in the bacterial cytoplasm, was functional, stimulating Mx and PKR expression in CHSE-214 cells, and reducing the IPNV viral load in SHK-1 cells. In vivo, the oral administration of this L. lactis producer of Interferon I increases Mx and PKR expression, mainly in the spleen, and to a lesser extent, in the head kidney. The oral administration of this strain also reduces the IPNV viral load in Atlantic salmon specimens challenged with this pathogen. Our results show that oral administration of L. lactis producing Interferon I induces systemic effects in Atlantic salmon, allowing to stimulate the antiviral immune response. This probiotic could have effects against a wide variety of viruses that infect Atlantic salmon and also be effective in other salmonids due to the high identity among their type I interferons.
format Text
author Muñoz, Carlos
González-Lorca, Josue
Parra, Mick
Soto, Sarita
Valdes, Natalia
Sandino, Ana María
Vargas, Rodrigo
González, Alex
Tello, Mario
author_facet Muñoz, Carlos
González-Lorca, Josue
Parra, Mick
Soto, Sarita
Valdes, Natalia
Sandino, Ana María
Vargas, Rodrigo
González, Alex
Tello, Mario
author_sort Muñoz, Carlos
title Lactococcus lactis Expressing Type I Interferon From Atlantic Salmon Enhances the Innate Antiviral Immune Response In Vivo and In Vitro
title_short Lactococcus lactis Expressing Type I Interferon From Atlantic Salmon Enhances the Innate Antiviral Immune Response In Vivo and In Vitro
title_full Lactococcus lactis Expressing Type I Interferon From Atlantic Salmon Enhances the Innate Antiviral Immune Response In Vivo and In Vitro
title_fullStr Lactococcus lactis Expressing Type I Interferon From Atlantic Salmon Enhances the Innate Antiviral Immune Response In Vivo and In Vitro
title_full_unstemmed Lactococcus lactis Expressing Type I Interferon From Atlantic Salmon Enhances the Innate Antiviral Immune Response In Vivo and In Vitro
title_sort lactococcus lactis expressing type i interferon from atlantic salmon enhances the innate antiviral immune response in vivo and in vitro
publisher Frontiers Media S.A.
publishDate 2021
url http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406758/
https://doi.org/10.3389/fimmu.2021.696781
genre Atlantic salmon
genre_facet Atlantic salmon
op_source Front Immunol
op_relation http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406758/
http://dx.doi.org/10.3389/fimmu.2021.696781
op_rights Copyright © 2021 Muñoz, González-Lorca, Parra, Soto, Valdes, Sandino, Vargas, González and Tello
https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
op_rightsnorm CC-BY
op_doi https://doi.org/10.3389/fimmu.2021.696781
container_title Frontiers in Immunology
container_volume 12
_version_ 1766360420598153216